Human epididymal and prostatic tracts of vas deferens: Different contraction response to noradrenaline stimulation in isolated organ bath assay

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 150-155

  Colabufo, Nicola A ^a   Pagliarulo, Vincenzo ^a   Berardi, Francesco ^a   Contino, Marialessandra ^a   Perrone, Roberto ^a   Niso, Mauro ^a   Albo, Giancarlo ^a   de Rienzo, Gaetano ^a   Pagliarulo, Arcangelo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

1 Adrenoceptor antagonist; Alphuzosin; Doxazosin; Human vas deferens; Terazosin

Indexed keywords

ALPHUZOSIN; DOXAZOSIN; NORADRENALIN; TERAZOSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; EPIDIDYMIS; HUMAN; MUSCLE CONTRACTILITY; PERISTALSIS; PRIORITY JOURNAL; VAS DEFERENS;

ADRENERGIC ALPHA-AGONISTS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXAZOSIN; EPIDIDYMIS; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NOREPINEPHRINE; ORGAN SPECIFICITY; PRAZOSIN; PROSTATE; QUINAZOLINES; RECEPTORS, ADRENERGIC, ALPHA-1; STIMULATION, CHEMICAL; VAS DEFERENS;

EID: 35448964778     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.038     Document Type: Article

References (35)

1. Alm P. On the autonomic innervation of the human vas deferens. Brain Res. Bull. 9 (1982) 673-681
2. Amann R.P. A critical review of methods for evaluation of spermatogenesis from seminal characteristics. J. Androl. 2 (1981) 37-45
3. 1-adrenoceptor and uroselectivity. Prostate 30 (1997) 205-215
4. Banks F.C.L., Knight G.E., Calvert R.C., Thompson C.E., Morgan R.J., and Burnstock G. The purinergic component of human vas deferens contraction. Fertil. Steril. 85 (2006) 932-939
5. Boselli C., and Grana E. Mode of antagonism of methoctramine, AF-DX116 and hexahydrosiladifenidol in guinea-pig left atrium and ileum: comparison of Schild and resultant analysis. J. Auton. Pharm. 15 (1995) 115-127
6. Boselli C., Banchi L., Barbieri A., and Grana E. Profiles of the response to noradrenaline in the whole and bisected rat vas deferens. J. Auton. Pharm. 17 (1997) 97-107
7. Boselli C., Banchi L., and Grana E. Effect of calcium antagonists on the response to noradrenaline in the whole and bisected rat vas deferens. J. Auton. Pharm. 18 (1998) 297-306
8. Breslin D., Fields D.W., Chou T.C., Marion D.N., Kane M., Darracott Vaughan Jr. E., and Felsen D. Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha1-adrenergic antagonists in prostate. J. Urol. 149 (1993) 395-399
9. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87 (2007) 659-797
10. 2+ influx stimulated by diacylglycerol and PKC. Br. J. Pharmacol. 123 (1998) 317-325
11. Bylund D.B., Eikenberg D.G., Hieble J.P., Langer S.Z., Lefkowitz R., Minneman K.P., Molinof P.B., Ruffolo Jr. R.R., and Trendelembourg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46 (1994) 121-136
12. Cleary L., Slattery J., Bexis S., and Docherty J.R. Sympathectomy reveals a1A- and a1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br. J. Pharmacol. 143 (2004) 745-752
13. 2 ligands in isolated guinea-pig bladder. Naunyn-Schmiedeberg's Arch. Pharmacol. 138 (2003) 106-112
14. Giuliano F., Bernabe J., Droupy S., Alexandre L., and Allard J. A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats. BJU Int. 93 (2004) 605-608
15. Grasso M., Fortuna F., Lania C., and Blanco S. Ejaculatory disorders and α1-adrenoceptor antagonist therapy: clinical and experimental researches. J. Transl. Med. 4 (2006) 31-36
16. 1-adrenergic receptor subtype expression by bladder outlet obstruction. J. Urol. 167 (2002) 1513-1521
17. Johnson L., and Verner D.D. Effect of daily spermatozoon production but not age on transit time of spermatozoa through the human epididymis. Biol. Reprod. 39 (1988) 812-817
18. Jones R. Sperm survival versus degradation in the mammalian epididymis: a hypothesis. Biol. Reprod. 71 (2004) 1405-1411
19. Kaplan S.A. α-Blocker therapy: current update. Rev. Urol. 7 (2005) 34-42
20. Kenny B.A., Naylor A.M., Carter A.J., Read A.M., Greengrass P.M., and Wyllie M.G. Effect of alpha1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology 44 (1994) 52-57
21. Kishi I., Hata F., Takeuchi T., Ishii T., and Yagasaki O. Cooperation of ATP and norepinephrine in inducing contractile responses in guinea pig vas deferens. Jap. J. Pharmacol. 54 (1990) 253-256
22. Huidobro-Toro J.P., and Parada S. Co-transmission in the rat vas deferens: postjunctional synergism of noradrenaline and adenosine 5′triphosphate. Neurosci. Lett. 85 (1998) 339-344
23. Lepor D. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia. Rev. Urol. 8 (2002) 3-9
24. Lich J.R., Howerton L.W., and Amin M. In: Harrison J.H., et al. (Ed). Anatomy and Surgical Approach to the Urogenital Tract in the Male in Campbells Urology vol. 1 (1978), WB Saunders, Philadelphia 3-33
25. McConnell J., Benson G.S., and Wood J.G. Autonomic innervation of the urogenital system: adrenergic and cholinergic elements. Brain Res. Bull. 9 (1982) 679-694
26. Montorsi F., and Moncada I. Safety and tolerability of treatment for BPH. Eur. Urol. Suppl. 5 (2006) 1004-1012
27. 1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions. Br. J. Pharmacol. 122 (1997) 1009-1014
28. Neaves W.B. In: Greep R.O., and Astwood E.B. (Eds). Biological Aspects of Vasectomy in Handbook of Physiology (1975), Williams and Wilkins, Baltimore 383-404
29. Neaves W.B., Johnson L., and Petty C.S. Age-related change in numbers of other interstitial cells in testis of adult men: evidence bearing on the fate of Leydig cells lost with increasing age. Biol. Reprod. 33 (1985) 259-269
30. Prins G.S., and Zaneveld L.J.D. Radiographic study of fluid transport in the rabbit vas deferens during sexual rest and after sexual activity. J. Reprod. Fertil. 58 (1980) 311-319
31. Sjöstrand N.O. The adrenergic innervation of the vas deferens and the accessory male genital glands. Acta Physiol. Scand. 65 (1965) 5-22
32. Smith N.C.E., and Burnstock G. Mechanism underlying postjunctional synergism between responses of the vas deferens to noradrenaline and ATP. Eur. J. Pharmacol. 498 (2004) 241-248
33. Tainio H. Peptidergic innervation of the human prostate, seminal vesicle and vas deferens. Acta Histochem. 97 (1995) 113-119
34. Tambaro S., Ruiu S., Dessi C., Mongeau R., Marchese G., and Pani L. Evaluation of tamsulosin and alphuzosin activity in the rat vas deferens: relevance in ejaculation delay. J. Pharmacol. Exp. Ther. 312 (2005) 710-717
35. Witt P.A., Kramer T.H., and Burks T.F. Norepinephrine and ATP are synergistic in the mouse vas deferens preparation. Eur. J. Pharmacol. 204 (1991) 149-155